
| How healthcare must respond to ventilator-associated pneumonia (VAP) in invasively mechanically ventilated COVID-19 patients #MMPMID33653643Szarpak L; Wisco J; Boyer RAm J Emerg Med 2021[Oct]; 48 (?): 361-362 PMID33653643show ga
?|Anti-Bacterial Agents/*therapeutic use[MESH]|COVID-19/*therapy[MESH]|Humans[MESH]|Intensive Care Units[MESH]|Intubation, Intratracheal/*instrumentation[MESH]|Pneumonia, Aspiration/*prevention & control[MESH]|Pneumonia, Ventilator-Associated/*prevention & control[MESH]|Respiration, Artificial[MESH]|SARS-CoV-2[MESH]
  
DeepDyve Pubget Overpricing | 
|